New York, NY -- (SBWIRE) -- 03/08/2021 -- The global In-Vitro Diagnostics (IVD) Quality Control Market was valued at USD 881.8 Million in 2018 and is expected to reach USD 1229.3 Million by year 2026, at a CAGR of 4.3%

Factors including increasing prevalence of chronic diseases, launch of new clinical laboratories, stringent mandates, as well as rising need of early diagnostics by patients drive the growth of In-Vitro Diagnostics (IVD) Quality Control market. Increasing incidence of public-private laboratories which are undergoing laboratory accreditation procedure even boosts up the growth of this particular market. For instance: In August 2018, Abbott Laboratories introduced Alinity, its state-of-the-art, harmonized family of systems for clinical diagnostics, to the US market indicating high demand for the systems' advanced capabilities and potential to provide savings and increased efficiencies for labs, clinicians, and hospitals.

Leading Players Profiled in the Report Include:

Agilent Diagnostics, Abbott Diagnostics, Becton, Dickson and Company, Bio-Rad Laboratories, Inc., and ThermoFisher Scientific

Get a PDF sample copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/1508

For the purpose of this purpose, Reports and Data have segmented the In-Vitro Diagnostics Quality Control Systems market on the basis of types, applications end use and region.

Manufacturer Type (Revenue, USD Million; 2016–2026)

Instrument Manufacturer Controls
Independent Manufacturer Controls
Third-party Controls
Instrument Specific Manufacturer Controls

Application (Revenue, USD Million; 2016–2026)

Clinical Chemistry
Immunochemistry
Haematology
Molecular Diagnostics
Coagulation/Haemostasis
Microbiology
Others

End User (Revenue, USD Million; 2016–2026)

Hospitals
Clinical Laboratories
Home Care
Others

Request a customized sample of the report @ https://www.reportsanddata.com/request-customization-form/1508

Further key findings from the report suggest:

The American Clinical Laboratory Association (ACLA) states that more than 7.5 billion lab tests are performed in U.S. annually and 80% of clinical decisions are taken after lab testing

In December 2018, BioMérieux announced its culture bottles BACT/ALERT® BPA and BPN have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for quality control testing of leukocyte-reduced apheresis platelet (LRAP) units with the BACT/ALERT® VIRTUO® fully automated blood culture system

In-Vitro Diagnostics (IVD) Quality Control Market is fastest growing at a CAGR of 3% in Asia Pacific owing to rising incidence of IVD tests in developing countries such as India and China due to upsurge in number of clinical laboratories, global awareness among patients

FDA is encouraging convergence of regulatory systems for medical devices, which is anticipated to boost trade, while protecting public health through regulatory means

Data Management Solutions segment is accounted to be the second-leading segment which is valued at USD 155.6 million because it gives access to LIS and easy for managing test results of patients and even popular due to dependable laboratory outcomes

Europe is the second largest region with a CAGR of 4.0% due to acceptance of point of care diagnostics across Europe especially in regions in UK, Denmark, Poland and Slovenia….Continue

Table of Content:

Chapter 1. Market Synopsis

1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2018 – 2026

Chapter 3. Indicative Metrics

3.1. Growing number of chronic diseases
3.2. Growing awareness among patients and physicians
3.3. Advance R&D facilities and new product developments by companies

Chapter 4. In-Vitro Diagnostics (IVD) Quality Control Segmentation & Impact Analysis

4.1. In-Vitro Diagnostics (IVD) Quality Control Segmentation Analysis
4.2. In-Vitro Diagnostics (IVD) Quality Control Market Value Chain Analysis, 2016-2026

Continue…

Leave a Query@ https://www.reportsanddata.com/make-enquiry-form/1508

Browse Related Reports:

Biomarkers Market Size, Trends & Analysis, By Product, By Type, By Application, By Disease Indication And Region, Segment Forecasts To 2027

Oncology Molecular Diagnostics Market Size, Share & Analysis, By Cancer Type, By Component, By Technology, By End-User, and Region, Segment Forecasts to 2027

Thank you for reading our report. In case of further queries regarding the report or inquiry about its customization, please connect with us. We will ensure your report is well-suited to your requirements.